Effects of conantokins on l-3,4-dihydroxyphenylalanine-induced behavior and immediate early gene expression

Add time:09/24/2019    Source:sciencedirect.com

Conantokins, peptides from Conus snails, are N-methyl-d-aspartate (NMDA) receptor antagonists. NMDA receptor antagonists potentiate l-3,4-dihydroxyphenylalanine (l-DOPA)-induced rotation in 6-hydroxydopamine-treated rodents, an index of anti-Parkinsonian potential. This study examined the effects of conantokin-G, conantokin-T(G), CGS 19755, and ifenprodil on l-DOPA-induced contralateral rotation and immediate early gene (IEG) expression in 6-hydroxydopamine-treated rats. Rats received unilateral infusions of 6-hydroxydopamine into the medial forebrain bundle. Three weeks later, rats were treated with an NMDA receptor antagonist, followed by an injection of l-DOPA. Contralateral rotations were recorded for 2 h. In addition, the expression of zif268 and c-fos were examined. Conantokin-G, conantokin-T(G), and CGS 19755 potentiated l-DOPA-induced rotation. Conantokin-G and ifenprodil had no effect on l-DOPA-induced IEG expression, whereas conantokin-T(G) and CGS 19755 attenuated expression. These data suggest that conantokins may be useful in treating Parkinson's disease. Furthermore, different NMDA receptor antagonists have distinct effects on striatal gene expression.

We also recommend Trading Suppliers and Manufacturers of L-3,4-DIHYDROXYPHENYLALANINE METHYL ESTER HYDROCHLORIDE (cas 1421-65-4). Pls Click Website Link as below: cas 1421-65-4 suppliers

Prev:Uptake of etrophine and dihydromorphine after sublingual and intramuscular administration
Next:l-3,4-Dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic l-amino acid decarboxylase)